Valuation: GC Genome Corporation

Market Cap 193B 141M 124M 117M 107M 200M 13.57B 201M 1.41B 545M 6.9B 531M 519M 22.47B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 134M 97.93K 86.14K 81.2K 74.08K 139K 9.4M 140K 974K 378K 4.78M 368K 360K 15.57M EV / Sales 2026 *
3.44x
EV / Sales 2027 * 2.55x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day+12.21%
1 week+16.86%
Current month+38.18%
1 month+51.76%
3 months+83.20%
6 months+9.80%
Current year+19.94%
1 week 6,580
Extreme 6580
8,350
1 month 5,310
Extreme 5310
8,350
Current year 4,100
Extreme 4100
9,520
1 year 4,100
Extreme 4100
9,520
3 years 4,100
Extreme 4100
15,180
5 years 4,100
Extreme 4100
15,180
10 years 4,100
Extreme 4100
15,180
Manager TitleAgeSince
Chief Executive Officer 57 26/03/2020
Director of Finance/CFO 50 27/03/2025
Comptroller/Controller/Auditor 45 29/03/2024
Director TitleAgeSince
Director/Board Member 57 30/03/2023
Date Insider Type Main position Quantity % Market Cap. Importance
17/6/25 Free

Chief Executive Officer

169,285 -
17/6/25 Free 138,250 --
Change 5-day change 1-year change 3-year change Capi.($)
+12.21%+16.86%+2.51% - 141M
+1.36%+11.31%+151.24%+809.69% 58.92B
+0.26%-3.31%+12.29%+48.78% 25.06B
-0.63%-2.34%-12.69%-38.65% 6.55B
-0.98%-7.49%-6.40%+149.06% 5.61B
-0.46%+2.92%+19.73%+63.65% 3.41B
+0.44%-13.46%-22.55%+2,350.70% 2.64B
-1.28%-3.57%+144.12%+55.34% 2.51B
+17.67%+2.71%+36.82%+44.85% 2.3B
+1.10%+8.21%-0.81%-52.89% 2B
Average +2.94%+0.43%+32.43%+381.17% 10.92B
Weighted average by Cap. +1.07%+4.44%+87.53%+514.37%

Financials

2026 *2027 *
Net sales 39B 28.49M 25.06M 23.62M 21.55M 40.3M 2.73B 40.62M 283M 110M 1.39B 107M 105M 4.53B 48.8B 35.65M 31.35M 29.56M 26.97M 50.43M 3.42B 50.82M 355M 137M 1.74B 134M 131M 5.67B
Net income - -
Net Debt -59.4B -43.39M -38.16M -35.98M -32.82M -61.39M -4.17B -61.86M -432M -167M -2.12B -163M -159M -6.9B -68.8B -50.26M -44.2M -41.67M -38.02M -71.1M -4.82B -71.65M -500M -194M -2.46B -189M -185M -7.99B
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
23/09/26 KRW 8,180.00 +12.21% 1,188,856
22/09/26 KRW 7,290.00 +7.68% 808,005
21/09/26 KRW 6,770.00 -1.88% 82,408
18/09/26 KRW 6,900.00 -1.43% 148,168
17/09/26 KRW 7,000.00 +4.01% 437,733

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A340450 Stock